Skip to main content

Table 2 Factors associated with a positive depression screening test

From: Prevalence of depressive symptoms in pregnant and postnatal HIV-positive women in Ukraine: a cross-sectional survey

  Positive depression screening test Fisher’s exact test
Antenatal survey
 Living as only adult in household?
  No 25 % (42/167) p=0.02
  Yes 58 % (7/12)  
 Severity of ART side effects
  Not bothered by side effects or only slightly 23 % (30/129) p=0.05
  Somewhat or terribly bothered by side effects 40 % (17/43)  
 Level of confidence that antenatal ART is effective for PMTCT
  Completely/fairly sure that it is effective 25 % (43/169) p=0.06
  Not at all sure that it is effective 56 % (5/9)  
 Self-efficacy score for integration of ART into daily life
  ≥5 (higher self-efficacy) 23 % (25/110) p=0.05
  <5 (lower self-efficacy) 43 % (12/28)  
Postnatal survey
 Marital status
  Married 19 % (19/99) p<0.01
  Co-habiting 21 % (18/84)  
  Single 44 % (20/45)  
 Can neonatal prophylaxis help prevent MTCT?
  Yes 18 % (28/154) p<0.01
  Not sure/No 40 % (25/63)  
 Ever worried that neonatal prophylaxis could harm baby
  Yes/a little 30 % (44/146) p<0.01
  No 14 % (10/73)  
 Self-rated ability to ask for support with taking medicationa
  Confident I could do 15 % (4/26) p=0.05
  Fairly confident could do 27 % (10/37)  
  Could not do 48 % (11/23)  
  1. ART – antiretroviral therapy; MTCT – mother-to-child transmission
  2. aAvailable for 86 of the 101 women on ART at time of postnatal survey completion